Clinical trial
Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17…
NCT00464815 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00464815 |
|---|---|
| Title | Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects |
| Official title | Primary Vaccination Study in Subjects Aged 11-17 Years to Demonstrate the Non-inferiority of GSK Biologicals' Meningococcal Vaccine GSK134612 Vaccine Versus Mencevax™ ACWY |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Meningococcal |
| Intervention type | Biological |
| Interventions | Meningococcal vaccine GSK134612, Mencevax™ ACWY |
| Enrollment | 1,025 |
| Start date | May 2, 2007 |
| Primary completion | Apr 16, 2008 |
| Completion | Sep 10, 2008 |
| First posted | Apr 24, 2007 |
| Last update posted | Jun 8, 2018 |
| Countries | India, Philippines, Taiwan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: